232 related articles for article (PubMed ID: 25493259)
1. Practical management and treatment of pancreatic neuroendocrine tumors.
Kondo NI; Ikeda Y
Gland Surg; 2014 Nov; 3(4):276-83. PubMed ID: 25493259
[TBL] [Abstract][Full Text] [Related]
2. MORPHOLOGICAL DIAGNOSIS OF PANCREATIC NEUROENDOCRINE TUMORS (REVIEW AND CASE REPORT).
Opanasenko D; Krychevska O; Kuryk O; Zakhartseva L; Rudnytska O
Georgian Med News; 2020 Nov; (308):101-109. PubMed ID: 33395650
[TBL] [Abstract][Full Text] [Related]
3. Surgical Management of Pancreatic Neuroendocrine Tumors.
Chiruvella A; Kooby DA
Surg Oncol Clin N Am; 2016 Apr; 25(2):401-21. PubMed ID: 27013372
[TBL] [Abstract][Full Text] [Related]
4. Management of Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEPNETs): A Review.
Pasricha G; Padhi P; Daboul N; Monga DK
Clin Ther; 2017 Nov; 39(11):2146-2157. PubMed ID: 29173655
[TBL] [Abstract][Full Text] [Related]
5. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
6. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications.
Strosberg JR; Cheema A; Weber JM; Ghayouri M; Han G; Hodul PJ; Kvols LK
Ann Surg; 2012 Aug; 256(2):321-5. PubMed ID: 22415420
[TBL] [Abstract][Full Text] [Related]
7. [2017 ENETS consensus guidelines: update for the standard of care of pancreatic neuroendocrine tumors].
Gao HL; Liu L; Wang WQ; Yu XJ
Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):809-812. PubMed ID: 30392299
[TBL] [Abstract][Full Text] [Related]
8. Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review.
Mauriello C; Napolitano S; Gambardella C; Candela G; De Vita F; Orditura M; Sciascia V; Tartaglia E; Lanza M; Santini L; Conzo G
Int J Surg; 2015 Sep; 21 Suppl 1():S10-4. PubMed ID: 26118605
[TBL] [Abstract][Full Text] [Related]
9. The value of gadoxetic acid-enhanced and diffusion-weighted MRI for prediction of grading of pancreatic neuroendocrine tumors.
Jang KM; Kim SH; Lee SJ; Choi D
Acta Radiol; 2014 Mar; 55(2):140-8. PubMed ID: 23897307
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.
Farrell JM; Pang JC; Kim GE; Tabatabai ZL
Cancer Cytopathol; 2014 Oct; 122(10):770-8. PubMed ID: 25044931
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
[TBL] [Abstract][Full Text] [Related]
12. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.
Kim JY; Hong SM
Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the World Health Organization 2010 grading system in surgical outcome and prognosis of pancreatic neuroendocrine tumors.
Yang M; Tian BL; Zhang Y; Su AP; Yue PJ; Xu S; Wang L
Pancreas; 2014 Oct; 43(7):1003-8. PubMed ID: 24945681
[TBL] [Abstract][Full Text] [Related]
14. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
[TBL] [Abstract][Full Text] [Related]
15. Recent updates on grading and classification of neuroendocrine tumors.
Kim JY; Hong SM; Ro JY
Ann Diagn Pathol; 2017 Aug; 29():11-16. PubMed ID: 28807335
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic Neuroendocrine Tumors - Case Series and Literature Review.
Mihalache O; Doran H; Poiană C; Bîrligea A; Cîrstea MO; Pătraşcu T
Chirurgia (Bucur); 2019; 114(5):630-638. PubMed ID: 31670639
[No Abstract] [Full Text] [Related]
17. [Differential diagnostic value of the expression of the transcription factor PDX-1 in neuroendocrine and non-neuroendocrine tumors of the pancreas and other organs].
Gurevich LE; Proshchina AE; Voronkova IA; Ashevskaya VE; Korosteleva PA; Dolzhansky OV
Arkh Patol; 2019; 81(5):11-21. PubMed ID: 31626200
[TBL] [Abstract][Full Text] [Related]
18. Emerging use of everolimus in the treatment of neuroendocrine tumors.
Gajate P; Martínez-Sáez O; Alonso-Gordoa T; Grande E
Cancer Manag Res; 2017; 9():215-224. PubMed ID: 28684922
[TBL] [Abstract][Full Text] [Related]
19. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.
Niederle MB; Hackl M; Kaserer K; Niederle B
Endocr Relat Cancer; 2010 Dec; 17(4):909-18. PubMed ID: 20702725
[TBL] [Abstract][Full Text] [Related]
20. Systemic Therapies for Advanced Pancreatic Neuroendocrine Tumors.
Raj N; Reidy-Lagunes D
Hematol Oncol Clin North Am; 2016 Feb; 30(1):119-33. PubMed ID: 26614372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]